Unknown

Dataset Information

0

Use of glasgow-blatchford bleeding score reduces hospital stay duration and costs for patients with low-risk upper GI bleeding.


ABSTRACT: BACKGROUND AND STUDY AIMS:Upper gastrointestinal (UGI) bleeding is a frequent cause of hospitalization. Its severity may be assessed before endoscopy using the Glasgow-Blatchford Bleeding Score (GBS), a score validated to identify patients requiring clinical intervention. The aim of this study was to assess whether the GBS was effective for shortening hospital stay and reducing costs in patients with an UGI bleeding predicted at low risk of requiring clinical intervention. PATIENTS AND METHODS:Consecutive outpatients presenting with UGI bleeding at our hospital were prospectively included. In the observational study phase, UGI endoscopy was performed in all patients according to routine clinical practice. In the interventional study phase, patients with a GBS of 0 were discharged with an appointment for an outpatient UGI endoscopy. All patients had follow-up at 7 and 30 days. Need for clinical intervention was defined as performance of endoscopic hemostasis, blood transfusion or surgery. Results Two-hundred and eight patients were included, 104 in each study phase; complete follow-up was obtained in 201 patients. GBS varied from 0 to 18, with 15 (14?%) and 11 (11?%) patients having a GBS of 0 in the observational and interventional study phase, respectively. For patients with a GBS of 0, hospital stay was shorter (6 versus 19?h, P?< 0.01), and costs were lower (845 EUR versus 1272 EUR, P?=?0.002) in the interventional versus the observational study phase. For patients with a GBS?>?0, hospital stay duration did not significantly differ between study phases (189 versus 207?h, P?=?0.726). No adverse event was observed in the patients sent home with a GBS of 0 during the interventional study phase. Conclusions Implementing the GBS as a tool for triage of hospital outpatients who present with UGI bleeding allowed us to identify those who could safely be discharged for ambulatory management. Implementing this change in the hospital strategy significantly shortened hospital stay and decreased management costs.

SUBMITTER: Girardin M 

PROVIDER: S-EPMC4423275 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC5517200 | BioStudies
2016-01-01 | S-EPMC4902479 | BioStudies
2017-01-01 | S-EPMC5539671 | BioStudies
1000-01-01 | S-EPMC5369468 | BioStudies
2015-01-01 | S-EPMC5049645 | BioStudies
2017-01-01 | S-EPMC5217768 | BioStudies
2020-01-01 | S-EPMC7427596 | BioStudies
2019-01-01 | S-EPMC6571241 | BioStudies
2021-01-01 | S-EPMC7937281 | BioStudies
2014-01-01 | S-EPMC4476431 | BioStudies